Ledger.Open graph →
SEC Form D · filed April 10, 2018

Tracon Pharmaceuticals, Inc

Offering
$75.7M
Sold
$38.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Martin L. Mattingly · SAN DIEGO, CADirectorWilliam L. Larue · SAN DIEGO, CADirectorCharles P. Theuer · SAN DIEGO, CAExec · DirectorPaul R. Walker · SAN DIEGO, CADirectorStephen R. Worland · SAN DIEGO, CADirectorJ. R. Twiford · SAN DIEGO, CADirectorPatricia L. Bitar · SAN DIEGO, CAExecTed R. Wang · SAN DIEGO, CADirectorDavid Chase · Seattle, WADirectorMelissa Taylor · Seattle, WADirectorNatalie A. Riley · Dexter, MODirectorSean Schantzen · Seattle, WAExecJeffrey Staub · St. Louis, MODirectorScott Howard · Pownal, MEExec · DirectorElizabeth Gallegos · St. Louis, MODirectorToby T. Rogers · DALLAS, TXDirectorWayne Joseph · Richardson, TXDirectorLaurence Barr · Cedar Hill, TXDirectorKent Wallace · Houston, TXExec · DirectorJohn J. Guinee · Andover, MAExecBrian Henry · Houston, TXDirectorRonald E. Wilhelm · New Yourk, NYDirectorTed R. Wang · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗